http://orcid.org/0000-0002-4473-7077
References
- Tandan M, Cormican M, Vellinga A. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: a systematic review and meta-analysis of randomized controlled trials. Internation J Antimicrob Agents. 2018;52(5):529–540.
- Baddour LM, Dayer MJ, Thornhill MH. Fluoroquinolone use and associated adverse drug reactions in England. J Infect. 2018;78:252–254.
- Thornhill MH, Dayer MJ, Durkin MJ, et al. Risk of adverse reactions to oral antibiotics prescribed by dentists. J Dent Res. 2019;98(10):1081–1087.
- Doi Y, Chambers HF. Penicillins and β-lactamase inhibitors In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennettt’s principles and practice of infectious diseases. Updated edition, 2015;20:263–277.e3. Philadelphia (PA): Elsevier Saunders.
- Brown KA, Khanafer N, Daneman N, et al. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326–2332.
- Hansen MP, Scott AM, McCullough A, et al. Adverse events in people taking macrolide antibiotics versus placebo for any indication. Cochrane Database Syst Rev. 2019;(1):CD011825.